Literature DB >> 6469091

Immediate vaginal reconstruction following resection for malignancy using the gluteal thigh flap.

B M Achauer, P Braly, M L Berman, P J DiSaia.   

Abstract

Immediate flap closure of perineal defects following extirpative procedures for gynecologic malignancies is highly desirable. Advantages include more rapid healing, reduced infection rate, decreased nutritional demands, early rehabilitation, greater safety in radiated fields, and more functional results. The posterior thigh flap, deriving its blood supply from the inferior gluteal artery, was used in 7 patients (9 flaps) with excellent results. The flap has proven reliable and quite feasible at the time of resection. While most partial pelvic or vaginal defects can be reconstructed with a single flap, bilateral flaps are recommended for more extensive defects. The major postoperative problem has been discomfort while sitting and paresthesias along the distribution of the posterior cutaneous nerve. To avoid these problems, the flap should be rotated distal to the ischium and, in subtotal reconstruction, the nerve excluded.

Entities:  

Mesh:

Year:  1984        PMID: 6469091     DOI: 10.1016/0090-8258(84)90162-8

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Reconstruction of acquired defects of the vagina and perineum.

Authors:  Christopher J Salgado; Harvey Chim; Piotr P Skowronski; John Oeltjen; Meily Rodriguez; Samir Mardini
Journal:  Semin Plast Surg       Date:  2011-05       Impact factor: 2.314

Review 2.  Technical advances of plastic and reconstructive surgery in cancer surgery.

Authors:  Kiyonori Harii
Journal:  Int J Clin Oncol       Date:  2005-08       Impact factor: 3.402

3.  Internal pudendal perforator artery-based gull wing flap for vulvovaginal 3D reconstruction after tumour excision: a new flap.

Authors:  Hyun H Han; Daiwon Jun; Bommie F Seo; Suk-Ho Moon; Deuk Y Oh; Sang T Ahn; Jong-Won Rhie
Journal:  Int Wound J       Date:  2015-01-14       Impact factor: 3.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.